Results 231 to 240 of about 30,514 (251)
Direct crosstalk between GPCRs and ion channels via G proteins. [PDF]
Kim SH, Kim J, So I, Lee HH.
europepmc +1 more source
ATP depletion in anthrax edema toxin pathogenesis. [PDF]
Liu J +7 more
europepmc +1 more source
Attention-deficit/hyperactivity disorder: insights, advances and challenges in research and practice. [PDF]
Prasad S, Kumminimana R.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The Cox-2-Specific Inhibitor Celecoxib Inhibits Adenylyl Cyclase
Inflammation, 2003Nonsteroidal anti-inflammatory drugs (NSAIDs) are well-known causes of acute renal insufficiency and gastropathy in patients with chronic inflammatory diseases. This action is presumed to result from nonselective inhibition of both constitutive and inducible forms of prostaglandin H synthases, also known as the cyclooxygenase enzymes (i.e., COX-1 amd ...
Shamsher S, Saini +2 more
openaire +2 more sources
Inhibitors of membranous adenylyl cyclases with affinity for adenosine receptors
Naunyn-Schmiedeberg's Archives of Pharmacology, 2015Membrane-bound adenylyl cyclases constitute an interesting therapeutic target for various diseases that affect a large number of patients including asthma or congestive heart failure. Many inhibitors of adenylyl cyclases are competitive inhibitors at the ATP binding site and may, therefore, also interact with one or several of numerous ATP-binding ...
Karl-Norbert, Klotz, Sonja, Kachler
openaire +2 more sources
Towards selective inhibitors of adenylyl cyclase toxin from Bordetella pertussis
Trends in Microbiology, 2012Whooping cough is a very important medical problem that requires novel approaches for treatment. The disease is caused by Bordetella pertussis, with the calmodulin (CaM)-activated adenylyl cyclase (AC) toxin (also known as CyaA) being a major virulence factor.
Roland, Seifert, Stefan, Dove
openaire +2 more sources
Identification of an Adenylyl Cyclase Inhibitor for Treating Neuropathic and Inflammatory Pain
Science Translational Medicine, 2011In animal models, an adenylyl cyclase 1 inhibitor acts as an effective treatment for neuropathic pain, in part by acting on the anterior cingulate cortex.
Hansen, Wang +11 more
openaire +2 more sources

